ReviewNPJ dementia2026
"Micro-managing" immune activation and protein turnover: microglial lysosomes in the context of health and disease.
Review in NPJ dementia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Compartment-Specific Lysosomal Heterogeneity in Microglia Is Regulated by Adaptor Protein Complex-4.bioRxiv : the preprint server for biology · 2026Article
- Cystatin F as a neuroimmune effector in CNS inflammation and neurodegeneration.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Lysosomes, central to protein and organelle homeostasis in all cells, have more recently been recognized as critical to other cellular processes, including nutrient sensing, cell metabolism, immune response, and programmed cell death. Tied into these varied functions, their composition as well as location within cells, lysosomes are now recognized to be made of heterogeneous subpopulations. Mechanisms that build and help maintain lysosome heterogeneity, its role in cell physiology, and links to pathologies are only now being worked out. Lysosome dysfunction has been associated with the pathogenesis of several neurodegenerative diseases. Neurons, which are particularly sensitive to lysosome dysfunction, are perhaps where lysosome biogenesis and transport, as well as its heterogeneity, are best studied in the nervous system. However, there is a growing interest in understanding lysosomal biogenesis and trafficking in other cell types of the nervous system, including microglia. In this review, we focus on key studies that have shed insight into microglial lysosome biology: its regulation, composition, and function, and how these properties are linked to immune activation, aging, and certain disease pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.